GT-02037
/ GlyTech
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
April 24, 2024
Investigational drugs for the Treatment of Acromegaly: new agents to transform therapy.
(PubMed, Expert Opin Investig Drugs)
- "The aim of current review is to provide a detailed update about investigational drugs for acromegaly treatment currently under investigation as paltusotine, ONO-5788, AP102, GT-02037, ISIS 766,720, CAM2024, Lanreotide PRF, DP1038, MTD201, solid dose injection of octreotide. Current studies are addressing patient's needing for both new molecules and less invasive routes of administration for already existing drugs. It cannot be ruled out that drugs currently used for other disease such as cancers could be considered in the future for the treatment of acromegaly."
Journal • Review • Acromegaly • Endocrine Disorders • Oncology
1 to 1
Of
1
Go to page
1